|
|
|
Volumn 25, Issue 12, 2011, Pages
|
|
Veliparib plus temozolomide in metastatic melanoma trends toward increased PFS but results are not statistically significant.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 ((R) 2 METHYLPYRROLIDIN 2 YL) 1H BENZIMIDAZOLE 4 CARBOXAMIDE;
2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE;
ANTINEOPLASTIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
DACARBAZINE;
DRUG DERIVATIVE;
TEMOZOLOMIDE;
ARTICLE;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE FREE SURVIVAL;
DOUBLE BLIND PROCEDURE;
HUMAN;
MELANOMA;
METASTASIS;
MORTALITY;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BENZIMIDAZOLES;
DACARBAZINE;
DISEASE-FREE SURVIVAL;
DOUBLE-BLIND METHOD;
HUMANS;
MELANOMA;
NEOPLASM STAGING;
|
|
EID: 84856618275
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|